Abstract:MicroRNAs (miRNAs) are evolutionally conserved, single-stranded RNAs that regulate gene expression at the posttranscriptional level by disrupting translation. MiRNAs are key players in variety of biological processes that regulate the differentiation, development and activation of immune cells in both innate and adaptive immunity. The disruption and dysfunction of miRNAs can perturb the immune response, stimulate the release of inflammatory cytokines and initiate the production of autoantibodies, and contribute to the pathogenesis of autoimmune diseases, including systemic lupus erythmatosus (SLE), rheumatoid arthritis (RA), primary biliary cholangitis (PBC), and multiple sclerosis (MS). Accumulating studies demonstrate that miRNAs, which can be collected by noninvasive methods, have the potential to be developed as diagnostic and therapeutic biomarkers, the discovery and validation of which is essential for the improvement of disease diagnosis and clinical monitoring. Recently, with the development of detection tools, such as microarrays and NGS (Next Generation Sequencing), large amounts of miRNAs have been identified and suggest a critical role in the pathogenesis of autoimmune diseases. Several miRNAs associated diagnostic biomarkers have been developed and applied clinically, though the pharmaceutical industry is still facing challenges in commercialization and drug delivery. The development of miRNAs is less advanced for autoimmune diseases compared with cancer. However, drugs that target miRNAs have been introduced as candidates and adopted in clinical trials. This review comprehensively summarizes the differentially expressed miRNAs in several types of autoimmune diseases and discusses the role and the significance of miRNAs in clinical management. The study of miRNAs in autoimmunity promises to provide novel and broad diagnostic and therapeutic strategies for a clinical market that is still in its infancy.

Microrna Involvement in Lupus: the Beginning of A New Tale

Analysis of Microrna-199A-3p Expression in CD4 + T Cells of Systemic Lupus Erythematosus

Novel insight into miRNA biology and its role in the pathogenesis of systemic lupus erythematosus

MicroRNAs in Systemic Lupus Erythematosus: a Perspective on the Path from Biological Discoveries to Clinical Practice

Novel Insights Of Micrornas In The Development Of Systemic Lupus Erythematosus

Long Non-Coding RNAs in Systemic Lupus Erythematosus: New Insights into Disease Pathogenesis and Diagnosis.

Mirnas in the Pathogenesis of Systemic Lupus Erythematosus

The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis

MicroRNAs—novel regulators of systemic lupus erythematosus pathogenesis

MicroRNA in Systemic Lupus Erythematosus

Recent Research on Microrna Involved in the Pathogenesis of Systemic Lupus Erythematosus

Regulation of B-cell function by miRNAs impacting Systemic lupus erythematosus progression

MicroRNAs in the Pathogenesis of Systemic Lupus Erythematosus

Research progress on microRNAs’ role in the pathogenesis of systemic lupus erythematosus

Abnormal Expression of Micrornas and Mutual Regulation Between Micrornas and DNA Methylation in Systemic Lupus Erythematosus

Promising Roles of Exosomal microRNAs in Systemic Lupus Erythematosus

Expanding Roles of Noncoding RNAs in the Pathogenesis of Systemic Lupus Erythematosus

MicroRNAs as Key Regulators in RA and SLE: Insights into Biological Functions

MicroRNA-146A Contributes to Abnormal Activation of the Type I Interferon Pathway in Human Lupus by Targeting the Key Signaling Proteins.

Clinical Significance of Mirnas in Autoimmunity

The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus